Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Yanping Chen, Yong Lin, Shou‐En Lu, Weichung J. Shih, Hui Quan
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867006264033148928
author Yanping Chen
Yong Lin
Shou‐En Lu
Weichung J. Shih
Hui Quan
author_facet Yanping Chen
Yong Lin
Shou‐En Lu
Weichung J. Shih
Hui Quan
Yanping Chen
Yong Lin
Shou‐En Lu
Weichung J. Shih
Hui Quan
collection Wiley Open Access
contents Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers Yanping Chen Yong Lin Shou‐En Lu Weichung J. Shih Hui Quan Statistics in Medicine Biomarker stratified clinical trial designs are versatile tools to assess biomarker clinical utility and address its relationship with clinical endpoints. Due to imperfect assays and/or classification rules, biomarker status is prone to errors. To account for biomarker misclassification, we consider a two‐stage stratified design for survival outcomes with an adjustment for misclassification in predictive biomarkers. Compared to continuous and/or binary outcomes, the test statistics for survival outcomes with an adjustment for biomarker misclassification is much more complicated and needs to take special care. We propose to use the information from the observed biomarker status strata to construct adjusted log‐rank statistics for true biomarker status strata. These adjusted log‐rank statistics are then used to develop sequential tests for the global (composite) hypothesis and component‐wise hypothesis. We discuss the power analysis with the control of the type‐I error rate by using the correlations between the adjusted log‐rank statistics within and between the design stages. Our method is illustrated with examples of the recent successful development of immunotherapy in nonsmall‐cell lung cancer. 10.1002/sim.10048 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1002/sim.10048
format Artículo Open Access
id wiley_oa_10_1002_sim_10048
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
Yanping Chen
Yong Lin
Shou‐En Lu
Weichung J. Shih
Hui Quan
Statistics in Medicine
Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers Yanping Chen Yong Lin Shou‐En Lu Weichung J. Shih Hui Quan Statistics in Medicine Biomarker stratified clinical trial designs are versatile tools to assess biomarker clinical utility and address its relationship with clinical endpoints. Due to imperfect assays and/or classification rules, biomarker status is prone to errors. To account for biomarker misclassification, we consider a two‐stage stratified design for survival outcomes with an adjustment for misclassification in predictive biomarkers. Compared to continuous and/or binary outcomes, the test statistics for survival outcomes with an adjustment for biomarker misclassification is much more complicated and needs to take special care. We propose to use the information from the observed biomarker status strata to construct adjusted log‐rank statistics for true biomarker status strata. These adjusted log‐rank statistics are then used to develop sequential tests for the global (composite) hypothesis and component‐wise hypothesis. We discuss the power analysis with the control of the type‐I error rate by using the correlations between the adjusted log‐rank statistics within and between the design stages. Our method is illustrated with examples of the recent successful development of immunotherapy in nonsmall‐cell lung cancer. 10.1002/sim.10048 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
topic Statistics in Medicine
url https://onlinelibrary.wiley.com/doi/10.1002/sim.10048